By Professor Dedee Frances Murrell

Journal articles

Jain SV; Murrell DF, 2018, 'Psychosocial impact of inherited and autoimmune blistering diseases', International Journal of Women's Dermatology, 4, pp. 49 - 53, http://dx.doi.org/10.1016/j.ijwd.2017.11.004

Drucker AM; Eyerich K; de Bruin-Weller MS; Thyssen JP; Spuls PI; Irvine AD; Girolomoni G; Dhar S; Flohr C; Murrell DF; Paller AS; Guttman-Yassky E, 2018, 'Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement', British Journal of Dermatology, 178, pp. 768 - 775, http://dx.doi.org/10.1111/bjd.15928

Bauer JW; Paller A; Mellerio JE; Hovnanian A; Pan JJ; Zografaos P; Licholai GP; Murrell DF, 2018, 'Use of an Investigator's Global Assessment Scale to Evaluate Disease Severity in Patients swith Epidermolysis Bullosa Simplex', SKIN The Journal of Cutaneous Medicine, 2, pp. S55 - S55, http://dx.doi.org/10.25251/skin.2.supp.55

Amber KT; Murrell DF; Schmidt E; Joly P; Borradori L, 2018, 'Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management', Clinical Reviews in Allergy and Immunology, 54, pp. 26 - 51, http://dx.doi.org/10.1007/s12016-017-8633-4

Yang A; Kim M; Craig P; Murrell DF, 2018, 'A case report of the use of rituximab and the epidermolysis bullosa disease activity scoring index (EBDASI) in a patient with epidermolysis bullosa acquisita with extensive esophageal involvement', Acta Dermatovenerologica Croatica, 26, pp. 325 - 328

Kim M; Li M; Intong-Wheeler LRA; Tran K; Marucci D; Murrell DF, 2018, 'Epidemiology and outcome of squamous cell carcinoma in epidermolysis bullosa in Australia and New Zealand', Acta Dermato-Venereologica, 98, pp. 70 - 76, http://dx.doi.org/10.2340/00015555-2781

Lee J; Werth VP; Hall RP; Eming R; Fairley JA; Fajgenbaum DC; Harman KE; Jonkman MF; Korman NJ; Ludwig RJ; Murrell DF; Musette P; Naik HB; Sadik CD; Yamagami J; Yale ML; Payne AS, 2018, 'Perspective from the 5th international pemphigus and pemphigoid foundation scientific conference', Frontiers in Medicine, 5, http://dx.doi.org/10.3389/fmed.2018.00306

Murrell D; Paller A; Bodemer C; Barth JA; Lagast H; Reha A, 2018, '585 Natural history of wound closure and other clinical endpoints in epidermolysis bullosa: Lessons from a 90-day multicenter trial', Journal of Investigative Dermatology, 138, pp. S99 - S99, http://dx.doi.org/10.1016/j.jid.2018.03.593

Murrell DF; Daneshpahzooh M; Meymandi S; Wiest LG, 2018, 'International chapters and membership of WDS are growing', International Journal of Women's Dermatology, 4, pp. 240 - 240, http://dx.doi.org/10.1016/j.ijwd.2018.10.005

Murrell D; Stavropoulos P; Patsatsi A; Zeeli T; Baum S; Bassukas I; Caux F; Roussaki A; Sinclair R; Kern J; Gourlay S; Joly P, 2018, 'LB1509 Anti-desmoglein levels & response to the BTK inhibitor PRN1008 in pemphigus', Journal of Investigative Dermatology, 138, pp. B7 - B7, http://dx.doi.org/10.1016/j.jid.2018.06.040

Drucker AM; Eyerich K; de Bruin-Weller MS; Thyssen JP; Spuls PI; Irvine AD; Girolomoni G; Dhar S; Flohr C; Murrell DF; Paller AS; Guttman-Yassky E, 2018, 'Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement', British Journal of Dermatology, 178, pp. e232 - e232, http://dx.doi.org/10.1111/bjd.16385

Drucker AM; Eyerich K; de Bruin-Weller MS; Thyssen JP; Spuls PI; Irvine AD; Girolomoni G; Dhar S; Flohr C; Murrell DF; Paller AS; Guttman-Yassky E, 2018, '对过敏性皮肤炎使用全身用糖皮质激素:国际湿疹理事会共识声明', British Journal of Dermatology, 178, pp. e246 - e246, http://dx.doi.org/10.1111/bjd.16452

Frew JW; Davidson M; Murrell DF, 2017, 'Disease-specific health related quality of life patient reported outcome measures in Genodermatoses: A systematic review and critical evaluation', Orphanet Journal of Rare Diseases, 12, pp. 189, http://dx.doi.org/10.1186/s13023-017-0739-5

Gollins CE; Shipman AR; Murrell DF, 2017, 'A study of the number of female editors-in-chief of dermatology journals', International Journal of Women's Dermatology, 3, pp. 185 - 188, http://dx.doi.org/10.1016/j.ijwd.2017.03.001

Murrell D, 2017, 'New developments in the management of congenital epidermolysis bullosa', Annales de Dermatologie et de Venereologie, 144, pp. S6 - S7, http://dx.doi.org/10.1016/j.annder.2017.09.587

Murrell DF; Sprecher E, 2017, 'Rituximab and short-course prednisone as the new gold standard for new-onset pemphigus vulgaris and pemphigus foliaceus', British Journal of Dermatology, 177, pp. 1143 - 1144, http://dx.doi.org/10.1111/bjd.15947

Kim EN; Harris AG; Bingham LJ; Yan W; Su JC; Murrell DF, 2017, 'A review of 52 pedigrees with epidermolysis bullosa simplex identifying ten novel mutations in KRT5 and KRT14 in Australia', Acta Dermato-Venereologica, 97, pp. 1114 - 1119, http://dx.doi.org/10.2340/00015555-2715

Frew JW; Murrell DF, 2017, 'Highly Resistant Acrodermatitis Continua of Hallopeau and Pustular Psoriasis', Skin Appendage Disorders, 3, pp. 179 - 181, http://dx.doi.org/10.1159/000464140

Patsatsi A; Kokolios M; Kyriakou A; Lamprou F; Stylianidou D; Tsapas A; Goulis DG; Murrell DF; Sotiriadis D, 2017, 'Quality of life in greek patients with autoimmune bullous diseases assessed with ABQOL and TABQOL indexes', Acta Dermato-Venereologica, 97, pp. 1145 - 1147, http://dx.doi.org/10.2340/00015555-2737

Murrell DF; Grant-Kels J, 2017, 'The International Journal of Women's Dermatology is now listed on PubMed Central', International Journal of Women's Dermatology, 3, pp. 126, http://dx.doi.org/10.1016/j.ijwd.2017.06.003

Kim E; Harris A; Hyland V; Murrell DF, 2017, 'Digenic inheritance in epidermolysis bullosa simplex involving two novel mutations in KRT5 and KRT14', British Journal of Dermatology, 177, pp. 262 - 264, http://dx.doi.org/10.1111/bjd.15053

Castrillón MA; Murrell DF, 2017, 'Lupus profundus limited to a site of trauma: Case report and review of the literature', International Journal of Women's Dermatology, 3, pp. 117 - 120, http://dx.doi.org/10.1016/j.ijwd.2017.03.002

Patsatsi A; Murrell DF, 2017, 'Multiple sclerosis is the neurological disorder most highly associated with bullous pemphigoid', British Journal of Dermatology, 176, pp. 1428 - 1429, http://dx.doi.org/10.1111/bjd.15581

Sekulic A; Migden MR; Basset-Seguin N; Garbe C; Gesierich A; Lao CD; Miller C; Mortier L; Murrell DF; Hamid O; Quevedo JF; Hou J; McKenna E; Dimier N; Williams S; Schadendorf D; Hauschild A, 2017, 'Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study', BMC Cancer, 17, pp. 332, http://dx.doi.org/10.1186/s12885-017-3286-5

Cheape AC; Murrell DF, 2017, '2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis', Expert Review of Clinical Immunology, 13, pp. 415 - 423, http://dx.doi.org/10.1080/1744666X.2017.1304820

Smithson SL; Rademaker M; Adams S; Bade S; Bekhor P; Davidson S; Dore A; Drummond C; Fischer G; Gin A; Grills C; Halbert A; Lokmic Z; McCahon E; Morgan VA; Murrell DF; Orchard D; Penington A; Purvis D; Relic J; Robertson S; Robinson AJ; Scardamaglia L; Su J; Tan S; Wargon O; Warren L; Wong LC; Zappala T; Phillips R, 2017, 'Consensus statement for the treatment of infantile haemangiomas with propranolol', Australasian Journal of Dermatology, 58, pp. 155 - 159, http://dx.doi.org/10.1111/ajd.12600

van Beek N; Dähnrich C; Johannsen N; Lemcke S; Goletz S; Hübner F; Di Zenzo G; Dmochowski M; Drenovska K; Geller S; Horn M; Kowalewski C; Medenica L; Murrell DF; Patsatsi A; Uzun S; Vassileva S; Zillikens D; Schlumberger W; Schmidt E, 2017, 'Prospective studies on the routine use of a novel multivariant enzyme-linked immunosorbent assay for the diagnosis of autoimmune bullous diseases', Journal of the American Academy of Dermatology, 76, pp. 889 - 894.e5, http://dx.doi.org/10.1016/j.jaad.2016.11.002

Harris AG; Todes-Taylor NR; Petrović N; Murrell DF, 2017, 'The distribution of epidermolysis bullosa in Australia with a focus on rural and remote areas', Australasian Journal of Dermatology, 58, pp. 122 - 125, http://dx.doi.org/10.1111/ajd.12431

Zhao CY; Hao EY; Oh DD; Daniel BS; Martin LK; Su JC; Rodrigues M; Murrell DF, 2017, 'A comparison study of clinician-rated atopic dermatitis outcome measures for intermediate- to dark-skinned patients', British Journal of Dermatology, 176, pp. 985 - 992, http://dx.doi.org/10.1111/bjd.15271

Jain SV; Harris AG; Su JC; Orchard D; Warren LJ; McManus H; Murrell DF, 2017, 'The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI): grading disease severity and assessing responsiveness to clinical change in epidermolysis bullosa', Journal of the European Academy of Dermatology and Venereology, 31, pp. 692 - 698, http://dx.doi.org/10.1111/jdv.13953

Miloslavsky EM; Naden RP; Bijlsma JWJ; Brogan PA; Brown ES; Brunetta P; Buttgereit F; Choi HK; Dicaire JF; Gelfand JM; Heaney LG; Lightstone L; Lu N; Murrell DF; Petri M; Rosenbaum JT; Saag KS; Urowitz MB; Winthrop KL; Stone JH, 2017, 'Development of a Glucocorticoid Toxicity Index (GTI) using multicriteria decision analysis', Annals of the Rheumatic Diseases, 76, pp. 543 - 546, http://dx.doi.org/10.1136/annrheumdis-2016-210002

Cust AE; Murrell DF, 2017, 'Increasing prevalence but not incidence of psoriasis in the U.K.', British Journal of Dermatology, 176, pp. 568 - 569, http://dx.doi.org/10.1111/bjd.15331

Kalinska-Bienias A; Jakubowska B; Kowalewski C; Murrell DF; Wozniak K, 2017, 'Measuring of quality of life in autoimmune blistering disorders in Poland. Validation of disease – specific Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment Autoimmune Bullous Disease Quality of Life (TABQOL) questionnaires', Advances in Medical Sciences, 62, pp. 92 - 96, http://dx.doi.org/10.1016/j.advms.2016.07.002

Intong LRA; Choi SD; Shipman A; Kho YC; Hwang SJE; Rhodes LM; Walton JR; Chapman MG; Murrell DF, 2017, 'Retrospective evidence on outcomes and experiences of pregnancy and childbirth in epidermolysis bullosa in Australia and New Zealand', International Journal of Women's Dermatology, 3, pp. S1 - S5, http://dx.doi.org/10.1016/j.ijwd.2017.02.002

Yang B; Chen G; Yang Q; Yan X; Zhang Z; Murrell DF; Zhang F, 2017, 'Reliability and validity of the Chinese version of the autoimmune bullous disease quality of life (ABQOL) questionnaire', Health and Quality of Life Outcomes, 15, pp. 31, http://dx.doi.org/10.1186/s12955-017-0594-z

Wijayanti A; Zhao CY; Boettiger D; Chiang YZ; Ishii N; Hashimoto T; Murrell DF, 2017, 'The reliability, validity and responsiveness of two disease scores (BPDAI and ABSIS) for bullous pemphigoid: Which one to use?', Acta Dermato-Venereologica, 97, pp. 24 - 31, http://dx.doi.org/10.2340/00015555-2473

Stalder JF; Aubert H; Anthoine E; Futamura M; Marcoux D; Morren MA; Trzeciak M; Szalai Z; Veres K; Deleuran M; Vestergaard C; Boralevi F; Chu CY; De Raeve L; Svensson ; Fölster-Holst R; Buchner M; Takaoka R; Aoki V; Chernyshov P; Chernyshova L; Murrell DF; Zhao C; Mckinster CD; Von Kobyletzky L; Eichenfield L; Totri C; Lio P; Seneschal J; Moret L; Barbarot S, 2017, 'Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP score', Allergy: European Journal of Allergy and Clinical Immunology, 72, pp. 1713 - 1719, http://dx.doi.org/10.1111/all.13189

Murrell DF, 2017, 'Why have hospitalization rates for bullous pemphigoid soared?', British Journal of Dermatology, 176, pp. 5 - 6, http://dx.doi.org/10.1111/bjd.15190

Guttman-Yassky E; Yosipovitch G; Murrell D; Hanifin J, 2017, '012 Crisaborole ointment provides early relief of pruritus in two phase 3 clinical trials in patients with mild or moderate atopic dermatitis', Journal of Investigative Dermatology, 137, pp. S194 - S194, http://dx.doi.org/10.1016/j.jid.2017.07.108

Grant-Kels J; Murrell D, 2017, 'To the Associate Editors and Reviewers of the International Journal of Women’s Dermatology and the Board of Directors of the Women’s Dermatologic Society', International Journal of Women's Dermatology, 3, pp. 1 - 2, http://dx.doi.org/10.1016/j.ijwd.2017.01.008

Murrell DF, 2016, 'A lesson learned about predatory journals and their difference from peer-reviewed open-access publishing', International Journal of Women's Dermatology, 2, pp. 113 - 114, http://dx.doi.org/10.1016/j.ijwd.2016.08.004

Kizny Gordon A; McIver C; Kim M; Murrell DF; Taylor P, 2016, 'Clinical application of a molecular assay for the detection of dermatophytosis and a novel non-invasive sampling technique', Pathology, 48, pp. 720 - 726, http://dx.doi.org/10.1016/j.pathol.2016.08.006

Hanna S; Kim M; Murrell DF, 2016, 'Validation studies of outcome measures in pemphigus', International Journal of Women's Dermatology, 2, pp. 128 - 139, http://dx.doi.org/10.1016/j.ijwd.2016.10.003

Kim M; Borradori L; Murrell DF, 2016, 'Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management', Drugs and Aging, 33, pp. 711 - 723, http://dx.doi.org/10.1007/s40266-016-0402-1

Kozera EK; Yang A; Murrell DF, 2016, 'Patient and practitioner satisfaction with tele-dermatology including Australia's indigenous population: A systematic review of the literature', International Journal of Women's Dermatology, 2, pp. 70 - 73, http://dx.doi.org/10.1016/j.ijwd.2016.06.004

Zhao CY; Murrell DF, 2016, 'Blistering diseases in neonates', Current Opinion in Pediatrics, 28, pp. 500 - 506, http://dx.doi.org/10.1097/MOP.0000000000000381

See JA; Shumack S; Murrell DF; Rubel DM; Fernández-Peñas P; Salmon R; Hewitt D; Foley P; Spelman L, 2016, 'Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia', Australasian Journal of Dermatology, 57, pp. 167 - 174, http://dx.doi.org/10.1111/ajd.12354

Boulard C; Duvert Lehembre S; Picard-Dahan C; Kern JS; Zambruno G; Feliciani C; Marinovic B; Vabres P; Borradori L; Prost-Squarcioni C; Labeille B; Richard MA; Ingen-Housz-Oro S; Houivet E; Werth VP; Murrell DF; Hertl M; Benichou J; Joly P; Hofmann S; Camaioni B; Didona B; Fania L; Della Torre R; Caux F; Alexandre M; Paul C; Bulai Livideanu C; Delaporte E; Dupuy A; Avenel-Audran M; Schmidt E; Schumacher N; Bagot M; Tancrede-Bohin E; Bouaziz JD; D'Incan M; Quereux G; Skowron F; Beylot-Barry M; Doutre MS; Bedane C; Bernard P; Machet L; Jullien ; Debarbieux S; Dereure O; Hünefeld C; Schanz S; Franck N; Maillard H; Misery L; Sassolas B; Abasq C; Bouyeure AC; Lagoutte P; Ferranti V, 2016, 'Calculation of cut-off values based on the Autoimmune Bullous Skin Disorder Intensity Score (ABSIS) and Pemphigus Disease Area Index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus', British Journal of Dermatology, 175, pp. 142 - 149, http://dx.doi.org/10.1111/bjd.14405

Zhao CY; Chiang YZ; Murrell DF, 2016, 'Neonatal autoimmune blistering disease: A systematic review', Pediatric Dermatology, 33, pp. 367 - 374, http://dx.doi.org/10.1111/pde.12859

Chalmers JR; Simpson E; Apfelbacher CJ; Thomas KS; von Kobyletzki L; Schmitt J; Singh JA; Svensson ; Williams HC; Abuabara K; Aoki V; Ardeleanu M; Awici-Rasmussen M; Barbarot S; Berents TL; Block J; Bragg A; Burton T; Bjerring Clemmensen KK; Creswell-Melville A; Dinesen M; Drucker A; Eckert L; Flohr C; Garg M; Gerbens LAA; Graff ALB; Hanifin J; Heinl D; Humphreys R; Ishii HA; Kataoka Y; Leshem YA; Marquort B; Massuel MA; Merhand S; Mizutani H; Murota H; Murrell DF; Nakahara T; Nasr I; Nograles K; Ohya Y; Osterloh I; Pander J; Prinsen C; Purkins L; Ridd M; Sach T; Schuttelaar MLA; Shindo S; Smirnova J; Sulzer A; Synnøve Gjerde E; Takaoka R; Vestby Talmo H; Tauber M; Torchet F; Volke A; Wahlgren CF; Weidinger S; Weisshaar E; Wollenberg A; Yamaga K; Zhao CY; Spuls PI, 2016, 'Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)', British Journal of Dermatology, 175, pp. 69 - 79, http://dx.doi.org/10.1111/bjd.14773

Back to profile page